Brand Name: UPLIZNA
Generic Name: Inebilizumab
Primary Class: CD19-directed Antibody Interactions [MoA]
SPL Set ID: 834db232-afb0-4dcf-93e0-009ce8245c20 view on Dailymed | RXCUI: 2373955
Manufacturer Name: Horizon Therapeutics USA, Inc.
| Package NDC | Description |
|---|---|
| 75987-150-03 | 3 VIAL, SINGLE-DOSE in 1 CARTON (75987-150-03) / 10 mL in 1 VIAL, SINGLE-DOSE (75987-150-01) |